Avalere Health
An Inovalon Company
Services

Federal & State Healthcare Policy

Predict Change

As the nation continues to struggle with improving outcomes, elevating quality, reducing costs, and driving value, federal and state policy activities remain core to making sound decisions for your business. Armed with policy experts and business strategists, Avalere guides organizations through the continued complexities of all aspects of healthcare public policy at both the federal and state levels. We help companies understand how changes to healthcare policy will affect coverage, access, payment, care delivery, and consumer choice. We partner with stakeholders from across the healthcare spectrum to help plan for insurance market reforms, Medicaid, Medicare Advantage, and Medicare Part D changes.

What's Your Challenge?

  • ​Policy Impact and Analysis
  • ​Policy Tracking and Monitoring
  • ​Comment Letters
  • ​Beneficiary Enrollment Trends

Complementary Products

Team

Meet a few of our experts ready to partner with you.

All Staff

Elizabeth Carpenter

Senior Vice President

Elizabeth
Carpenter

Elizabeth Carpenter, Senior Vice President, leads the Policy Practice at Avalere. Specifically, Elizabeth focuses on implementation of the Affordable Care Act, trends in commercial insurance, drug pricing policy, and the impact of politics on the policy landscape. 

Prior to joining Avalere, Elizabeth was a Senior Advisor in the Health Policy practice at McKenna Long & Aldridge LLP and the Associate Policy Director for the Health Policy Program at the New America Foundation. Previously, she served on both the legislative and campaign staffs of Senator Lincoln Chafee (RI).

Elizabeth has a BA in Political Science from Brown University.

Brenda Huneycutt

Vice President

Brenda
Huneycutt

Brenda Huneycutt, PhD, JD, MPH, Vice President in Avalere’s FDA Strategy and Regulatory Policy practice, advises clients on regulatory strategy and policy spanning drugs, biologics and diagnostics, and conducts due diligence assessments for clients looking to acquire or in-license products. Using her molecular biology research background, combined with her legal and public health policy training, Brenda helps clients translate technical information into clear descriptions for various audiences, and offers special expertise in regulatory strategy for FDA approval strategies involving accelerated and new pathways, including breakthrough therapy and orphan designations, and biosimilars and interchangeable biologics. 

Prior to joining Avalere, Brenda conducted research at the Genetics and Public Policy Center at Johns Hopkins University and was an Patent Attorney for Finnegan, LLP.

Brenda has a BA in Biology from the University of Delaware; a PhD in Molecular, Cellular, and Developmental Biology from the University of Colorado at Boulder; a JD from the George Washington University School of Law; and a MPH from Johns Hopkins Bloomberg School of Public Health.

Colleen Hopkins

Senior Associate

Colleen
Hopkins

Colleen Hopkins, Senior Associate, advises life sciences clients on the policy impacts of health reform on their commercial and advocacy priorities. She focuses on state implementation of the Affordable Care Act’s health insurance exchanges, part D policy and payment, and assisting pharmaceutical companies with changing policy landscapes. 

Prior to joining Avalere, Colleen was a Senior Associate at Community Anti-Drug Coalitions of America (CADCA), where she identified and interpreted novel research for use in evidence-based strategies related to tobacco prevention policies, cancer screenings and geographic health disparities. Prior to that, she worked as a Research Assistant for Information Innovators, Inc. where she conducted qualitative and quantitative research on telehealth systems in rural communities. 

Colleen has a BS in Biology from the University of Mary Washington and a Masters of Public Health from George Mason University.  

Clara Soh

Director

Clara
Soh

Clara Soh, Director, provides analysis for clients on the impact of legislation and regulation on business impacts. She applies her background in economics, evidence-based medicine, and policy analysis to help quantify the costs and value of healthcare services to patients and society. Clara has expertise in advising payers, providers, and manufacturers understand and navigate the constantly shifting reimbursement environment. 

Prior to joining Avalere, Clara was a Senior Director, Policy and Research, for Pharmaceutical Research and Manufacturers of America, conducting research and analysis around the value of prescription medicines and patient access. Prior to that, as a Research Associate at Kaiser Permanente Center for Health Research, she advised the U.S. Preventive Services Task Force on preventive health topics.

Clara has an MPA in Health Policy and Management from New York University and a BS in Molecular Biophysics and Biochemistry from Yale University.

« Back to Mobile Site